-54%

est. 2Y upside i

HealthcareSeries B

Anterior is the clinical AI platform built specifically for payers. We sit at the unique intersection of clinician expertise, explainable intelligence, and partner-driven deployment.

Rank

#840

Sector

Healthcare AI / Enterprise Systems

Est. Liquidity

~4Y

Data Quality

Data: Medium

Anterior operates in a high-growth healthcare AI market addressing significant administrative burdens, backed by top-tier VCs and demonstrating strong clinical accuracy.

Last updated: March 10, 2026

Bull (25%)+300%

Anterior rapidly expands its customer base, leveraging its 99.24% clinical accuracy and rapid deployment model to become a dominant player in healthcare administrative AI. Revenue scales to $50M-$65M ARR by 2028, justifying a $380M+ valuation (4x current) at a premium multiple (e.g., 6-8x revenue) as a clear market leader.

Base (50%)+75%

Anterior continues to grow steadily, securing additional health plan customers and expanding its product offerings within administrative workflows. Revenue reaches $30M-$40M ARR by 2028, leading to an acquisition or later-stage funding round at a $165M-$170M valuation (1.75x current), reflecting solid execution in a competitive market.

Bear (25%)-70%

Intense competition from well-funded direct competitors like Cohere Health (valued at $750M) and potential entry of large incumbents leads to slower customer acquisition and pricing pressure. Growth stalls, and a down round values the company at $25M-$30M (0.3x current), significantly eroding common stock value due to the $64M liquidation preference stack.

Est. time to liquidity~3.5 years

Preference Stack Risk

severe

Funding Intensity

67%

Investors hold $64M in liquidation preferences ahead of common stock. In an exit at or below $95M, common stock could see significantly reduced or no returns.

Dilution Risk

high

As a Series B company, future funding rounds will likely be required, leading to further dilution for existing common shareholders.

Secondary Liquidity

none

Given its early stage (~48 employees) and recent funding, there is currently no active secondary market for Anterior's shares.

Engineering — 1 role

View all 1 open roles at Anterior →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Anterior's data — designed to show you've done your homework.

  • 1

    “Given the estimated $6M in current revenue and the $95M valuation (likely from Series A), what are the company's specific growth targets and key performance indicators (KPIs) for the next 12-24 months to justify a substantial increase in valuation for future funding rounds or an exit?”

  • 2

    “With a $64M liquidation preference on a $95M valuation, how does Anterior plan to ensure meaningful returns for common shareholders in various exit scenarios, especially considering the competitive landscape with players like Cohere Health (valued at $750M)?”

  • 3

    “Anterior's 'Forward Deployed Clinician model' and deep integrations are key differentiators. How does the company plan to scale this resource-intensive model efficiently as it expands to support organizations covering 100 million lives, as per its 12-month goal?”

Community

Valuation Sentiment

Our model estimates -54% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.